Cochrane Abstracts
Adjuvant antiviral therapy for recurrent respiratory papillomatosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Adjuvant Antiviral Therapy for Recurrent Respiratory Papillomatosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439879/all/Adjuvant_antiviral_therapy_for_recurrent_respiratory_papillomatosis.
Adjuvant antiviral therapy for recurrent respiratory papillomatosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439879/all/Adjuvant_antiviral_therapy_for_recurrent_respiratory_papillomatosis. Accessed December 9, 2024.
Adjuvant antiviral therapy for recurrent respiratory papillomatosis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439879/all/Adjuvant_antiviral_therapy_for_recurrent_respiratory_papillomatosis
Adjuvant Antiviral Therapy for Recurrent Respiratory Papillomatosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439879/all/Adjuvant_antiviral_therapy_for_recurrent_respiratory_papillomatosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Adjuvant antiviral therapy for recurrent respiratory papillomatosis
ID - 439879
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439879/all/Adjuvant_antiviral_therapy_for_recurrent_respiratory_papillomatosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
